Sunstein Insights Shape Created with Sketch.

Back to All Publications

The Name Game: The USPTO and FDA approval process for the selection and protection of new drug names.

Lisa M. Tittemore

Lisa M. Tittemore | Partner, Litigation Chair View more articles

Lisa is a member of our Litigation Practice Group and Trademark Practice Group

File no longer available.

Subscribe to our Newsletters

Subscribe to: